Statement 26 September 2026

Consideration of the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR)

By IFPMA
Downloads
Statement
Share
Topics

On the occasion of the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response, Dr. David Reddy, Director General, IFPMA, said:

“The global pharmaceutical industry urges governments to seize the opportunity of the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR), and accelerate practical commitments that strengthen preparedness for future health crises.

“Medicines and vaccines will remain a cornerstone of pandemic prevention, preparedness, and response. As governments consider the Political Declaration, they should adopt policies that enable the discovery and development of life-saving products and strengthen the systems needed to deliver them rapidly, worldwide. Preparedness does not begin when a crisis hits. It is built through the choices countries make every day to value innovation and invest in resilient health systems.

“The pharmaceutical industry remains committed to partnering with governments, research institutions, international organizations, and civil society to strengthen preparedness and build a safer, more resilient world for all.”

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster
Top